Ubs Asset Management Americas Inc Cogent Biosciences, Inc. Transaction History
Ubs Asset Management Americas Inc
- $277 Billion
- Q1 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 69,557 shares of COGT stock, worth $587,061. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69,557
Previous 59,557
16.79%
Holding current value
$587,061
Previous $350,000
33.43%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding COGT
# of Institutions
159Shares Held
102MCall Options Held
197KPut Options Held
102K-
Kynam Capital Management, LP Princeton, NJ8.5MShares$71.7 Million5.99% of portfolio
-
State Street Corp Boston, MA7.63MShares$64.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.69MShares$56.5 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct6.68MShares$56.3 Million0.11% of portfolio
-
Commodore Capital LP New York, NY6.43MShares$54.2 Million3.73% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $555M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...